Navigation Links
NanoFUSE Biologics Names Renowned Surgeon Dr. Darren Lebl to Its Growing Scientific Advisory Board
Date:12/31/2019

NanoFUSE Biologics is pleased to announce the addition of Dr. Darren Lebl to its Scientific Advisory Board. NanoFUSE Biologics offers a biologically enhanced synthetic therapeutic, which is the only FDA-cleared bioactive glass and demineralized bone matrix (DBM) combined medical device.

President of NanoFUSE Biologics, Jake Lubinski, said, “We’re fortunate to have a NanoFUSE Scientific Advisory Board of the best spine and orthopedic surgeons who are at the forefront of biologics use. Dr. Lebl brings a wealth of prestigious and extensive experience with biologics and how those biologics are used to best care for patients. We are privileged to welcome Dr. Lebl as the latest member to our team.”

Dr Lebl noted, “I am honored to be part of the Scientific Advisory Board for NanoFUSE. Spine surgery continues to evolve toward less invasive techniques that require surgeons to have the latest in biologic technology like NanoFUSE to help us achieve fusion with consistently successful results”

Dr. Darren Lebl is an Associate Professor of spinal surgery specializing in minimally invasive surgery, the cervical spine, motion preserving spine procedures, and robotic computer guided navigation surgery. His practice at Hospital for Special Surgery in New York City involves a customized approach to each individual patient to help maximize quality of life and musculoskeletal health. He incorporates innovative procedures, newer and less invasive surgical techniques, and biologics into his practice
.
After obtaining a triple major in biochemistry & molecular biology, chemistry, and economics at The University of Chicago Dr. Lebl received his MD degree from Stanford. He completed his orthopedic residency at Harvard, a spine surgery fellowship at The Hospital for Special Surgery in New York City, and an MBA from Wharton. He pursued additional advanced spine surgery training in cervical spine disorders, occipitocervical disorders, and spinal deformity surgery with international leaders in the USA, China, Japan, Spain, and Germany.

About NanoFUSE Biologics

NanoFUSE is a biologically enhanced synthetic therapeutic that combines osteoinductive DBM with the osteostimulative properties of bioactive glass. NanoFUSE is the only FDA-cleared combination of DBM and bioactive glass and is indicated for use in general orthopedic applications. NanoFUSE Biologics is a KICVentures portfolio company and is distributed by SpineFrontier.

About KICVentures

KICVentures is a private investment holding company founded by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities and has a proven track-record of building the most disruptive spine technology portfolio, including AxioMed, NanoFUSE and SpineFrontier. It has headquarters in Boston, MA.

About Dr Darren Lebl

Dr. Lebl was the Editor-in-Chief of the Orthopedic Journal at Harvard Medical School and Academic Chief Resident at the Massachusetts General Hospital. He was later recognized as an “emerging leader” by the world’s oldest and most distinguished orthopedic association, the American Orthopedic Association, for his contributions to education and research. He has authored numerous peer-reviewed articles and book chapters on complication avoidance in spinal surgery, cervical spine disorders, minimally invasive procedures, and motion preserving spine procedures. Dr. Lebl was the director of both the Complex Cervical Spine Symposium and the Cervical Spine Motion Preservation Symposium at HSS. Dr. Lebl is a Fellow of the American Academy of Orthopedic Surgeons and an active member of distinguished societies such as the Cervical Spine Research Society, the North American Spine Society, and the Scoliosis Research Society.

Read the full story at https://www.prweb.com/releases/nanofuse_biologics_names_renowned_surgeon_dr_darren_lebl_to_its_growing_scientific_advisory_board/prweb16808791.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Orthopedic Surgeon, Dr. Mark McFarland, Completes Milestone Case With NanoFUSE® Biologics Technology
2. Biosimilars And Follow-On Biologics: World Market 2013-2023
3. Original Drugs Pave the Way for Follow-on Biologics
4. Synthetic Biologics to Host Multiple Sclerosis-Estriol Investor Day in New York City on June 25, 2013
5. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
6. For Moderate to Severe Psoriasis, Thought Leaders Opinions and Clinical Data Indicate That Emerging Biologics That Target IL-17 Have the Potential to Offer Improvements in Efficacy and Safety Over Current Therapies
7. Water Street Completes Investment in RTI Biologics Inc.
8. PharmAthene and Theraclone Sciences Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets
9. Former Pfizer/Wyeth Global Infectious Disease Pharmaceutical Executive, Lewis Barrett, Appointed Senior Vice President, Commercial Strategy of Synthetic Biologics, Inc.
10. Oncobiologics and inVentiv Health Form Strategic Partnership around Biosimilars
11. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2020)... (PRWEB) , ... March 20, 2020 , ... Today, in ... statewide to address the COVID-19 public health emergency, Mercy Medical Center sought ... to construct a new 32-bed acute care unit on the 17th floor of the ...
(Date:3/20/2020)... Calif. (PRWEB) , ... March 21, 2020 , ... On ... Health Screening Trailer Triage at Adventist Health Simi Valley. The ramp and platforms helped ... is considered to be an essential service as we install ramps that provide access ...
(Date:3/19/2020)... ... March 19, 2020 , ... Combining multiple food ... single food immunotherapy, according to research scheduled for presentation at the 2020 American ... due to the situation with coronavirus disease 2019 (COVID-19). , A retrospective ...
Breaking Medicine Technology:
(Date:3/30/2020)... , ... March 30, 2020 , ... ... and prospective patients, continuing its commitment to provide comprehensive and compassionate mental health ... can use Achieve Medical Center’s UpDox platform for telemedicine services including initial consultations, ...
(Date:3/28/2020)... ... March 27, 2020 , ... ... the public from the spread of the coronavirus. Operating under the designation as ... forward with infrastructure renewal and environmental protection projects in the downstate New York ...
(Date:3/28/2020)... ... March 28, 2020 , ... Confluent Health ... a physical therapist-owned rehabilitation company since 1985 specializing in the treatment of orthopedic, ... we started more than 30 years ago, we have been committed to providing ...
(Date:3/27/2020)... ... ... During a time of global distress and concern about the impact of COVID-19, T1 ... Education and Support Fund in an effort to assist hospitality workers whose jobs have ... working people in the food service , hotel and other major industries ...
(Date:3/22/2020)... ... March 22, 2020 , ... “At a time when the public is being ... Health Insurance Solutions’ First Stop Health Telemedicine program is a valuable resource ... Health Telemedicine program, is a valuable tool that can help Americans in their fight ...
Breaking Medicine News(10 mins):